Eculizumab in Posttransplant TMA: Unproven Benefit

Saved in:
Bibliographic Details
Main Authors: Romy N. Bouwmeester, Jack F.M. Wetzels, Nicole C.A.J. van de Kar
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Kidney International Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024924016358
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128048421076992
author Romy N. Bouwmeester
Jack F.M. Wetzels
Nicole C.A.J. van de Kar
author_facet Romy N. Bouwmeester
Jack F.M. Wetzels
Nicole C.A.J. van de Kar
author_sort Romy N. Bouwmeester
collection DOAJ
format Article
id doaj-art-20ec799b231c4090adc8fe357626b0f3
institution OA Journals
issn 2468-0249
language English
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Kidney International Reports
spelling doaj-art-20ec799b231c4090adc8fe357626b0f32025-08-20T02:33:31ZengElsevierKidney International Reports2468-02492024-06-0196192910.1016/j.ekir.2024.02.1442Eculizumab in Posttransplant TMA: Unproven BenefitRomy N. Bouwmeester0Jack F.M. Wetzels1Nicole C.A.J. van de Kar2Radboud University Medical Center, Amalia Children’s Hospital, Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Nijmegen, The Netherlands; Correspondence: Romy N. Bouwmeester, Radboud University Medical Center, Amalia Children's Hospital, Department of Pediatric Nephrology, P.O. Box 9101, 6500 HB, Nijmegen, The Netherlands.Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The NetherlandsRadboud University Medical Center, Amalia Children’s Hospital, Radboud Institute for Molecular Life Sciences, Department of Pediatric Nephrology, Nijmegen, The Netherlandshttp://www.sciencedirect.com/science/article/pii/S2468024924016358
spellingShingle Romy N. Bouwmeester
Jack F.M. Wetzels
Nicole C.A.J. van de Kar
Eculizumab in Posttransplant TMA: Unproven Benefit
Kidney International Reports
title Eculizumab in Posttransplant TMA: Unproven Benefit
title_full Eculizumab in Posttransplant TMA: Unproven Benefit
title_fullStr Eculizumab in Posttransplant TMA: Unproven Benefit
title_full_unstemmed Eculizumab in Posttransplant TMA: Unproven Benefit
title_short Eculizumab in Posttransplant TMA: Unproven Benefit
title_sort eculizumab in posttransplant tma unproven benefit
url http://www.sciencedirect.com/science/article/pii/S2468024924016358
work_keys_str_mv AT romynbouwmeester eculizumabinposttransplanttmaunprovenbenefit
AT jackfmwetzels eculizumabinposttransplanttmaunprovenbenefit
AT nicolecajvandekar eculizumabinposttransplanttmaunprovenbenefit